WBA Overview

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

Wall Street analysts forecast WBA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WBA is11.45 USD with a low forecast of 11.45 USD and a high forecast of 11.45 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Walgreens Boots Alliance Inc revenue for the last quarter amounts to 38.99B USD, increased 7.25

Walgreens Boots Alliance Inc. EPS for the last quarter amounts to -0.20 USD, decreased -150.00

Walgreens Boots Alliance Inc (WBA) has 193000 emplpoyees as of March 30 2026.

Today WBA has the market capitalization of 10.52B USD.